Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. Articles
  3. kidney therapy
Show results for
Products
Services
Applications

Companies

News
Articles
Downloads
Videos

Refine by
Date

  • Older

Kidney Therapy Articles & Analysis

8 articles found

Glycated Collagen Protein Detection

Glycated Collagen Protein Detection

Collagen is the most abundant protein in tissues and organs, and glycated collagen refers to collagen modified by glycosylation. Glycated collagen mainly exists in various tissues in the human body, especially those rich in collagen, such as skin, bones, joints, blood vessels, and other connective tissues.Under normal physiological conditions, glycation occurs as a natural biochemical process, ...

ByMtoZ Biolabs


Conceptual Considerations for Device-Based Therapy in Acute Decompensated Heart Failure

Conceptual Considerations for Device-Based Therapy in Acute Decompensated Heart Failure

It is noteworthy that while several of these therapies demonstrate short-term beneficial biochemical, symptomatic, and hemodynamic effects, these successes fail to translate into meaningful clinical outcomes (eg, reduced rates of rehospitalization or mortality).37–40 As a result, even in the 2019 ACC Expert Consensus Decision Pathway, there has been little advancement in ...

BySecond Heart Assist, Inc.


An Early Study on the Mechanisms that Allow Tissue-Engineered Vascular Grafts to Resist Intimal Hyperplasia

An Early Study on the Mechanisms that Allow Tissue-Engineered Vascular Grafts to Resist Intimal Hyperplasia

Abstract : Intimal hyperplasia is one of the prominent failure mechanisms for arteriovenous fistulas and arteriovenous access grafts. Human tissue-engineered vascular grafts (TEVGs) were implanted as arteriovenous grafts in a novel baboon model. Ultrasound was used to monitor flow rates and vascular diameters throughout the study. Intimal hyperplasia in the outflow vein of TEVGs was assessed at ...

ByHumacyte, Inc.


Five Year Outcomes in Patients with End Stage Renal Disease Who Received a Bioengineered Human Acellular Vessel for Dialysis Access

Five Year Outcomes in Patients with End Stage Renal Disease Who Received a Bioengineered Human Acellular Vessel for Dialysis Access

Objective: Patients with end stage renal failure who require haemodialysis suffer morbidity and mortality due to vascular access. Bioengineered human acellular vessels (HAVs) may provide a haemodialysis access option with fewer complications than other grafts. In a prospective phase II trial from 2012 to 2014 (NCT01744418), HAVs were implanted into 40 haemodialysis patients at three sites in ...

ByHumacyte, Inc.


Facing Treatment of Kidney Disease with Hearing Disabilities

Facing Treatment of Kidney Disease with Hearing Disabilities

Around 37 million people in the United States and around 700 million people worldwide have chronic kidney disease which require patients to utilize dialysis centers. These dialysis clinics provide lifesaving treatments to the patients that need them. While having any medical procedure performed, communication between the healthcare provider and the patient is vital to ...

BySafe’N’Clear, Inc.


3 Things That Google’s Healthcare Artificial Intelligence Desperately Needs

3 Things That Google’s Healthcare Artificial Intelligence Desperately Needs

Google DeepMind recently published a paper in Nature that shared how their predictive algorithm can detect Acute Kidney Injury (AKI) up to 48 hours in advance. Acute Kidney Injury is the biggest problem you have never heard of. In the US, 1 in 5 hospitalized adults gets Acute Kidney Injury, resulting in a 5x risk of death. It takes the lives of over 300,000 Americans every year. Globally, the ...

ByPotrero Medical


Costs Attributable to Arteriovenous Fistula and Arteriovenous Graft Placements in Hemodialysis Patients with Medicare coverage

Costs Attributable to Arteriovenous Fistula and Arteriovenous Graft Placements in Hemodialysis Patients with Medicare coverage

Access abandonment occurred at subsequent placement, transplantation, kidney function recovery, loss to follow-up, transition to non-HD renal replacement therapy, death, or end of study period (December 31, 2014). ...

ByHumacyte, Inc.


Arteriovenous Fistulae for Haemodialysis: A Systematic Review and Metaanalysis of Efficacy and Safety Outcomes

Arteriovenous Fistulae for Haemodialysis: A Systematic Review and Metaanalysis of Efficacy and Safety Outcomes

Keywords: Arteriovenous fistula, Haemodialysis, Patency, Maturation, Meta-analysis Introduction The use of chronic haemodialysis (HD) as renal replacement therapy (RRT) in patients with end stage renal disease (ESRD) is a prevalent practice worldwide and in the USA, and HD accounts for approximately 63% of RRT.1 The US Renal Data System estimated that there were 120,688 ...

ByHumacyte, Inc.

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT